Related Experiment Videos
'Nephritic factor' may be an autoantibody to C3b or C4b
The Tohoku Journal of Experimental Medicine
|April 1, 1981
Summary
Nephritic Factor (NeFA) in the alternative complement pathway appears to be an anti-C3b autoantibody, while Nephritic Factor (NeFC) in the classical pathway is an anti-C4b autoantibody, though they can co-occur.
Area of Science:
- Immunology
- Complement System Biology
Background:
- The complement system comprises distinct pathways, including the alternative and classical pathways.
- Nephritic Factor (NeF) is implicated in these pathways, but its precise characterization remains debated.
Purpose of the Study:
- To elucidate the specific roles and identities of Nephritic Factor in the alternative (NeFA) and classical (NeFC) complement pathways.
- To differentiate NeFA and NeFC based on their functional activities.
Main Methods:
- Utilized agglutinating and hemolytic activity assays to investigate NeFA and NeFC.
- Analyzed the functional characteristics of NeFA and NeFC within their respective complement pathways.
Main Results:
- Findings suggest NeFA and NeFC possess distinct functional capabilities.
- Demonstrated that NeFA and NeFC can manifest concurrently in certain conditions.
- Identified NeFA as an autoantibody targeting C3b and NeFC as an autoantibody targeting C4b.
Conclusions:
- Nephritic Factor activity in the alternative pathway (NeFA) is characterized as anti-C3b autoantibody.
- Nephritic Factor activity in the classical pathway (NeFC) is characterized as anti-C4b autoantibody.
- The distinct identities of NeFA and NeFC are established, with potential for co-occurrence.